LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 1120 | 10401 | 0.1077 | 0.0614 |
MCF 10A | Celastrol | 0.12 | uM | LJP6 | 72 | hr | 513 | 11759 | 10401 | 1.1306 | 1.1374 |
MCF 10A | CGP60474 | 0.12 | uM | LJP5 | 72 | hr | 513 | 677 | 10401 | 0.0651 | 0.0165 |
MCF 10A | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 513 | 550 | 10401 | 0.0529 | 0.0038 |
MCF 10A | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 513 | 9570 | 10401 | 0.9202 | 0.9160 |
MCF 10A | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10313 | 10401 | 0.9916 | 0.9911 |
MCF 10A | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10964 | 10401 | 1.0541 | 1.0570 |
MCF 10A | Crizotinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 8949 | 10401 | 0.8605 | 0.8532 |
MCF 10A | Momelotinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 8077 | 10401 | 0.7766 | 0.7650 |
MCF 10A | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 1768 | 10401 | 0.1700 | 0.1269 |
MCF 10A | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 741 | 10401 | 0.0713 | 0.0231 |
MCF 10A | Dovitinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 7328 | 10401 | 0.7046 | 0.6892 |
MCF 10A | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 513 | 10051 | 10401 | 0.9664 | 0.9646 |
MCF 10A | Erlotinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 8611 | 10401 | 0.8280 | 0.8190 |
MCF 10A | Foretinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 10269 | 10401 | 0.9873 | 0.9866 |
MCF 10A | R406 | 0.12 | uM | LJP6 | 72 | hr | 513 | 9549 | 10401 | 0.9181 | 0.9138 |
MCF 10A | Pictilisib | 0.12 | uM | LJP6 | 72 | hr | 513 | 3776 | 10401 | 0.3630 | 0.3300 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 2719 | 10401 | 0.2615 | 0.2231 |
MCF 10A | Geldanamycin | 0.12 | uM | LJP5 | 72 | hr | 513 | 528 | 10401 | 0.0508 | 0.0015 |
MCF 10A | Geldanamycin | 0.12 | uM | LJP6 | 72 | hr | 513 | 554 | 10401 | 0.0533 | 0.0041 |
MCF 10A | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 513 | 7518 | 10401 | 0.7228 | 0.7084 |
MCF 10A | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 513 | 5019 | 10401 | 0.4825 | 0.4557 |
MCF 10A | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 513 | 3050 | 10401 | 0.2932 | 0.2565 |
MCF 10A | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 513 | 607 | 10401 | 0.0584 | 0.0095 |
MCF 10A | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 513 | 9574 | 10401 | 0.9205 | 0.9164 |